Digital Eye Strain Affects 69% of People — What You Need to Know

Computer Vision Syndrome (CVS) has quietly become one of the most prevalent occupational and lifestyle health conditions of the digital era. A 2023 meta-analysis of 103 studies placed global CVS prevalence at 69.0% (95% CI: 62.2–75.4%), and pandemic-era data pushed that figure even higher — a 2024 systematic review found CVS symptoms in 74% of participants, driven by dramatic increases in remote work, online learning, and social media use. In China alone, social media usage rose 3.2 hours per week during COVID-19. Among Thai university students, each additional hour of daily screen time conferred a 12% increase in CVS risk.

The symptom burden of CVS spans both ocular and musculoskeletal domains. Ocular symptoms include dry eyes, blurred vision, eye strain, redness, burning, double vision, and photophobia, while extraocular symptoms encompass neck, shoulder, and back pain — reported at rates as high as 79–83% in some occupational samples. CVS also disrupts sleep by suppressing melatonin via blue light in the 440–550 nm range, impairs cognitive performance, and is linked to heightened rates of stress, anxiety, and depression. Reduced blink frequency during screen use worsens tear film stability, compounding dry eye symptoms.

Demographic and regional analysis reveals important disparities. Women show higher CVS prevalence (71.4%) than men (61.8%), partly due to hormonal influences on tear production and the tear-film-disrupting effects of eye cosmetics. Africa (71.2%) and Asia (69.9%) report higher rates than Europe (61.4%), reflecting gaps in ergonomic awareness and workplace setup quality — studies in Ghana and Ethiopia documented poor ergonomic practices in over 78% of workstations. University students carry the highest population-level burden at 76.1%, attributable to prolonged multi-device use, inadequate breaks, and limited ergonomic infrastructure, especially post-pandemic.

Management strategies reviewed span corrective optics, behavioral modification, and emerging technology. The widely marketed blue light-blocking spectacles and multifocal lenses show limited and inconsistent efficacy in reducing CVS symptoms. By contrast, wearable technologies — including smart glasses with near-eye tracking to monitor blink rate and posture — and AI-powered ergonomic assessment tools demonstrate meaningful promise in occupational settings. The 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds), optimized screen positioning, appropriate ambient lighting, and regular comprehensive eye exams remain evidence-supported pillars of prevention. Augmented reality is also flagged as an emerging risk factor warranting further study.

The review's key caveat is its narrative design, which limits systematic bias control and precludes meta-analytic pooling of management outcomes. Nonetheless, it offers a practical, cross-disciplinary synthesis valuable for clinicians, occupational health practitioners, and public health policymakers seeking to address a condition affecting the majority of screen-using populations worldwide.